Elsevier

Biochemical Pharmacology

Volume 34, Issue 11, 1 June 1985, Pages 1925-1929
Biochemical Pharmacology

Formation of β-phenylethylamine from the antidepressant, β-phenylethylhydrazine

https://doi.org/10.1016/0006-2952(85)90310-7Get rights and content

Abstract

To determine whether the monoamine oxidase inhibitor phenelzine was metabolized in vivo to produce β-phenylethylamine (PE) and p-hydroxy-β-phenylethylamine [p-tyramine (pTA)], a deuterated analogue, α,α,,β,β-2H-phenelzine (d4-phenelzine) was synthesized and injected i.p. into rats. In the first experiment, rat striata from d4-phenelzine-treated rats were analyzed for the presence of d4-PE and d4-pTA at a time at which phenelzine was known to cause particularly large increases in striatal pTA. While d4-PE was found to be present in these rat striata at a concentration equivalent to the endogenous PE, no d4-pTA was present. The amounts of d4-PE produced at various times after the i.p. injection of 50 mg/kg d4-phenelzine were measured; at 1 hr post-injection, 371 ± 60, 1295 ± 682 and 1242 ± 394 ng/g (mean ± S.E.M.) d4-PE were present in whole brain, liver and kidney. Rat urine collected for a 24-hr period after this treatment contained (mean ± S.E.M.) 88.5 ± 14.0 μg d4-PE. These results clearly indicate that the antidepressant phenelzine was metabolized in vivo to produce the trace amine PE.

References (17)

  • N.H. Neff et al.

    Life Sci.

    (1974)
  • B.V. Clineschmidt et al.

    Biochem. Pharmac.

    (1969)
  • B.V. Clineschmidt et al.

    Biochem. Pharmac.

    (1969)
  • D.A. Durden et al.

    Biochem. Pharmac.

    (1976)
  • A.A. Boulton et al.

    Life Sci.

    (1974)
  • L.E. Dyck et al.

    Biochem. Pharmac.

    (1983)
  • B.A. Davis et al.

    J. Chromat.

    (1982)
  • K.F. Tipton et al.

    Biochem. Pharmac.

    (1972)
There are more references available in the full text version of this article.

Cited by (28)

View all citing articles on Scopus
View full text